This role of ANGPTL2 in early atherosclerosis accords with the findings of a previous animal study, in which ANGPTL2 altered the release of nitric oxide, an important anti-atherogenic molecule [28], leading to endothelial dysfunction at stages of atherosclerosis preceding atherosclerotic plaque formation [9,14]. This evidence concerns the gene ANGPTL2 and atherosclerosis.